In vivo receptor binding of novel α1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia
- 27 March 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 62 (17-18) , 1585-1589
- https://doi.org/10.1016/s0024-3205(98)00111-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of KMD-3213, an α1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aortaEuropean Journal of Pharmacology, 1996
- Subtype selectivity of a new α1-adrenoceptor antagonist, JTH-601: comparison with prazosinEuropean Journal of Pharmacology, 1996
- The receptor occupation and plasma concentration of NKY‐722, a water‐soluble dihydropyridine‐type calcium antagonist, in spontaneously hypertensive ratsBritish Journal of Pharmacology, 1995
- Alpha1-adrenoceptors in human prostate: Characterization and binding characteristics of alpha1-antagonistsLife Sciences, 1994
- Investigation of the subtypes of α1‐adrenoceptor mediating contractions of rat aorta, vas deferens and spleenBritish Journal of Pharmacology, 1993
- Pharmacological subclassification of α1‐adrenoceptors in vascular smooth muscleBritish Journal of Pharmacology, 1990
- Subclassification of α1‐adrenoceptor recognition sites by urapidil derivatives and other selective antagonistsBritish Journal of Pharmacology, 1989
- α1Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscleNature, 1987
- Effects of Prazosin in Patients with Benign Prostatic ObstructionJournal of Urology, 1983
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978